Repurposing synthetic and natural derivatives induces apoptosis in an orthotopic glioma‐induced xenograft model by modulating WNT/β‐catenin signaling
Fundamental & Clinical Pharmacology · 2023-12 · 37 (6) · 1179-1197
DOI: 10.1111/fcp.12932 ↗At a glance
Journal article in Fundamental & Clinical Pharmacology, 2023-12. Written by Senthilathiban Daisy Precilla and 6 co-authors. Institution: Mahatma Gandhi Medical Advanced Research Institute (MGMARI), Sri Balaji Vidyapeeth (Deemed to-be University), Puducherry, 607 403, India. Major MEDLINE topics: Drug Repositioning, Apoptosis, Glioma, Wnt Signaling Pathway. Cited 8 times so far (Crossref); 129 references. Funded by: Indian Council of Medical Research.
Abstract (original language)
Background
Glioblastomas arise from multistep tumorigenesis of the glial cells. Despite the current state‐of‐art treatment, tumor recurrence is inevitable. Among the innovations blooming up against glioblastoma, drug repurposing could provide profound premises for treatment enhancement. While considering this strategy, the efficacy of the repurposed drugs as monotherapies were not up to par; hence, the focus has now shifted to investigate the multidrug combinations.
Aim
To investigate the efficacy of a quadruple‐combinatorial treatment comprising temozolomide along with chloroquine, naringenin, and phloroglucinol in an orthotopic glioma‐induced xenograft model.
Methods
Antiproliferative effect of the drugs was assessed by immunostaining. The expression profiles of WNT/β‐catenin and apoptotic markers were evaluated by qRT‐PCR, immunoblotting, and ELISA. Patterns of mitochondrial depolarization was determined by flow cytometry. TUNEL assay was performed to affirm apoptosis induction. In vivo drug detection study was carried out by ESI‐Q‐TOF MS analysis.
Results
The quadruple‐drug treatment had significantly hampered glioma proliferation and had induced apoptosis by modulating the WNT/β‐catenin signaling. Interestingly, the induction of apoptosis was associated with mitochondrial depolarization. The quadruple‐drug cocktail had breached the blood–brain barrier and was detected in the brain tissue and plasma samples.
Conclusion
The quadruple‐drug combination served as a promising adjuvant therapy to combat glioblastoma lethality in vivo and can be probed for translation from bench to bedside.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Mahatma Gandhi Medical Advanced Research Institute (MGMARI), Sri Balaji Vidyapeeth (Deemed to-be University), Puducherry, 607 403, India.
- Department of Pathology, Mahatma Gandhi Medical College and Research Institute (MGMCRI), Sri Balaji Vidyapeeth (Deemed to-be University), Puducherry, 607 403, India.
- Catalysis and Energy Laboratory, Department of Chemistry, Pondicherry University, Puducherry, 605 014, India.
- Department of Biochemistry and Molecular Biology, Pondicherry University, Puducherry, 605 014, India.
ORCID profiles: Senthilathiban Daisy Precilla, Thirugnanasambandhar Sivasubramanian Anitha
Funding
- Indian Council of Medical Research
Cite
APA
Daisy Precilla, S., Kuduvalli, S. S., Biswas, I., Bhavani, K., Pillai, A. B., Thomas, J. M., & Anitha, T. S. (2023). Repurposing synthetic and natural derivatives induces apoptosis in an orthotopic glioma‐induced xenograft model by modulating WNT/β‐catenin signaling. Fundamental & Clinical Pharmacology. https://doi.org/10.1111/fcp.12932
Vancouver
Daisy Precilla S, Kuduvalli SS, Biswas I, Bhavani K, Pillai AB, Thomas JM, et al. Repurposing synthetic and natural derivatives induces apoptosis in an orthotopic glioma‐induced xenograft model by modulating WNT/β‐catenin signaling. Fundamental & Clinical Pharmacology. 2023. doi:10.1111/fcp.12932
BibTeX
@article{DaisyPrecilla2023,
author = {Daisy Precilla, Senthilathiban and Kuduvalli, Shreyas S and Biswas, Indrani and Bhavani, Krishnamurthy and Pillai, Agieshkumar Balakrishna and Thomas, Jisha Mary and Anitha, Thirugnanasambandhar Sivasubramanian},
title = {Repurposing synthetic and natural derivatives induces apoptosis in an orthotopic glioma‐induced xenograft model by modulating WNT/β‐catenin signaling},
journal = {Fundamental & Clinical Pharmacology},
year = {2023},
doi = {10.1111/fcp.12932}
}
EUVIMED